Literature DB >> 189552

Localization of prolactin binding in prostate and testis: The role of serum prolactin concentration on the testicular LH receptor.

C Aragona, H G Bohnet, H G Friesen.   

Abstract

Specific binding sites for prolactin (PRL) and gonadotrophins on ventral and dorsolateral prostate as well as on Leydig cells and tubules of testes of rats at different ages were examined. The binding sites for PRL were found in greatest number in ventral prostate and in Leydig cells. LH binding sites were also more numerous than FSH binding sites in the latter. FSH sites were greater than LH sites in tubular preparations obtained from the testis. Specific binding (SB) of PRL in the Leydig cells reached a maximum at 45 days (4%) and in the case of LH a maximum of 12% was obtained at 70 days. In both preparations SB of FSH exhibited a plateau between 20 and 40 days (11%) followed by a gradual decline to 6% at 100 days. Following 20 dyas of treatment with Bromocriptin beginning at 20 days serum PRL was suppressed and SB of LH to the Leydig cells was significantly decreased, whereas SB of PRL and FSH was unaffected. These studies suggest that despite decreases in serum PRL, the number of PRL and FSH receptors remain unaltered. On the contrary, LH receptors in the rat testis are modulated by changes in serum PRL.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 189552     DOI: 10.1530/acta.0.0840402

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  14 in total

Review 1.  Morphologic and regulatory aspects of prostatic function.

Authors:  G Aumüller
Journal:  Anat Embryol (Berl)       Date:  1989

2.  The effect of ergobromocriptine on serum testosterone and prolactin levels in patients with carcinoma of the prostate.

Authors:  C Taşar; A Akdaş; Z Kirkali
Journal:  Int Urol Nephrol       Date:  1986       Impact factor: 2.370

3.  Immunocytochemical detection of prolactin or prolactin-like immunoreactivity in epididymis of mature male mouse.

Authors:  W B Brumlow; C S Adams
Journal:  Histochemistry       Date:  1990

4.  Anti-growth action on mouse mammary and prostate glands of a monoclonal antibody to prolactin receptor.

Authors:  J F Sissom; M L Eigenbrodt; J C Porter
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

5.  Treatment of advanced prostatic cancer with anti-androgens alone and a combination of anti-androgen with anti-prolactin--a pilot study.

Authors:  E Hoogendijk; H J de Voogt
Journal:  Urol Res       Date:  1986

6.  Effects of prolactin on the morphology and function of rat Leydig cells: short-term versus long-term administration.

Authors:  G Mazzocchi; L Cavallini; A Kasprzak; P Rebuffat; G G Nussdorfer
Journal:  Cell Tissue Res       Date:  1990-10       Impact factor: 5.249

7.  Micromethod for the determination of free and total prolactin receptors: measurement of receptor levels in normal and malignant mammary and prostate tissues.

Authors:  M Ben-David; T Kadar; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

8.  Determination and properties of proteohormone receptors in malignant gynecological tumors with special reference to lactogen receptors in human breast cancer.

Authors:  H G Bohnet
Journal:  Arch Gynecol       Date:  1980

9.  Prolactin oversuppression.

Authors:  H G Bohnet; D Mühlenstedt; J P Hanker; H P Schneider
Journal:  Arch Gynakol       Date:  1977-10-28

10.  Prolactin and male fertility: the long and short feedback regulation.

Authors:  M K Gill-Sharma
Journal:  Int J Endocrinol       Date:  2009       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.